Skip to content

In the BioHarmony Drug Report Database

Tepotinib

Tepmetko (tepotinib) is a small molecule pharmaceutical. Tepotinib was first approved as Tepmetko on 2021-02-03. The pharmaceutical is active against hepatocyte growth factor receptor. Tepmetko's patents are valid until 2030-03-19 (FDA).
Trade Name Tepmetko
Common Name Tepotinib
Indication
Drug Class Tyrosine kinase inhibitors
Tepotinib
Get full access now